These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18550372)

  • 21. Allosteric Molecular Switches in Metabotropic Glutamate Receptors.
    Orgován Z; Ferenczy GG; Keserű GM
    ChemMedChem; 2021 Jan; 16(1):81-93. PubMed ID: 32686363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3-(Imidazolyl methyl)-3-aza-bicyclo[3.1.0]hexan-6-yl)methyl ethers: a novel series of mGluR2 positive allosteric modulators.
    Zhang L; Rogers BN; Duplantier AJ; McHardy SF; Efremov I; Berke H; Qian W; Zhang AQ; Maklad N; Candler J; Doran AC; Lazzaro JT; Ganong AH
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5493-6. PubMed ID: 18812259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy switching SAR of mGluR5 allosteric modulators: highly potent positive and negative modulators from one chemotype.
    Sams AG; Mikkelsen GK; Brodbeck RM; Pu X; Ritzén A
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3407-10. PubMed ID: 21531137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel class of positive allosteric modulators of metabotropic glutamate receptor subtype 1 interact with a site distinct from that of negative allosteric modulators.
    Hemstapat K; de Paulis T; Chen Y; Brady AE; Grover VK; Alagille D; Tamagnan GD; Conn PJ
    Mol Pharmacol; 2006 Aug; 70(2):616-26. PubMed ID: 16645124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Acting at Site Distinct from 2-Methyl-6-(phenylethynyl)-pyridine Binding.
    Butkiewicz M; Rodriguez AL; Rainey SE; Wieting J; Luscombe VB; Stauffer SR; Lindsley CW; Conn PJ; Meiler J
    ACS Chem Neurosci; 2019 Aug; 10(8):3427-3436. PubMed ID: 31132237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression.
    Hughes ZA; Neal SJ; Smith DL; Sukoff Rizzo SJ; Pulicicchio CM; Lotarski S; Lu S; Dwyer JM; Brennan J; Olsen M; Bender CN; Kouranova E; Andree TH; Harrison JE; Whiteside GT; Springer D; O'Neil SV; Leonard SK; Schechter LE; Dunlop J; Rosenzweig-Lipson S; Ring RH
    Neuropharmacology; 2013 Mar; 66():202-14. PubMed ID: 22551786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New allosteric modulators of metabotropic glutamate receptor 5 (mGluR5) found by ligand-based virtual screening.
    Renner S; Noeske T; Parsons CG; Schneider P; Weil T; Schneider G
    Chembiochem; 2005 Apr; 6(4):620-5. PubMed ID: 15744765
    [No Abstract]   [Full Text] [Related]  

  • 28. Discovery of biological evaluation of pyrazole/imidazole amides as mGlu5 receptor negative allosteric modulators.
    Chae E; Shin YJ; Ryu EJ; Ji MK; Ryune Cho N; Lee KH; Jeong HJ; Kim SJ; Choi Y; Seok Oh K; Park CE; Soo Yoon Y
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2134-9. PubMed ID: 23434029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective Negative Allosteric Modulation Of Metabotropic Glutamate Receptors – A Structural Perspective of Ligands and Mutants.
    Harpsøe K; Isberg V; Tehan BG; Weiss D; Arsova A; Marshall FH; Bräuner-Osborne H; Gloriam DE
    Sci Rep; 2015 Sep; 5():13869. PubMed ID: 26359761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of molecular switches within the ADX-47273 mGlu5 PAM scaffold that modulate modes of pharmacology to afford potent mGlu5 NAMs, PAMs and partial antagonists.
    Lamb JP; Engers DW; Niswender CM; Rodriguez AL; Venable DF; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2011 May; 21(9):2711-4. PubMed ID: 21183344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery, synthesis, and structure-activity relationships of 2-aminoquinazoline derivatives as a novel class of metabotropic glutamate receptor 5 negative allosteric modulators.
    Kubas H; Meyer U; Krueger B; Hechenberger M; Vanejevs M; Zemribo R; Kauss V; Ambartsumova R; Pyatkin I; Polosukhin AI; Abel U
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4493-500. PubMed ID: 23856046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and SAR of novel, non-MPEP chemotype mGluR5 NAMs identified by functional HTS.
    Zhou Y; Rodriguez AL; Williams R; Weaver CD; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6502-6. PubMed ID: 19875287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3D-QSAR CoMFA study of benzoxazepine derivatives as mGluR5 positive allosteric modulators.
    Lowe EW; Ferrebee A; Rodriguez AL; Conn PJ; Meiler J
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5922-4. PubMed ID: 20732812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide].
    Satow A; Maehara S; Ise S; Hikichi H; Fukushima M; Suzuki G; Kimura T; Tanak T; Ito S; Kawamoto H; Ohta H
    J Pharmacol Exp Ther; 2008 Aug; 326(2):577-86. PubMed ID: 18487514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of novel heterobiaryl amides as metabotropic glutamate receptor subtype 5 antagonists.
    Kulkarni SS; Newman AH
    Bioorg Med Chem Lett; 2007 Apr; 17(7):2074-9. PubMed ID: 17336520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of Novel Central Nervous System Penetrant Metabotropic Glutamate Receptor Subtype 2 (mGlu
    Childress ES; Wieting JM; Felts AS; Breiner MM; Long MF; Luscombe VB; Rodriguez AL; Cho HP; Blobaum AL; Niswender CM; Emmitte KA; Conn PJ; Lindsley CW
    J Med Chem; 2019 Jan; 62(1):378-384. PubMed ID: 30350962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and synthesis of substituted N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamides as positive allosteric modulators of the metabotropic glutamate receptor subtype 5.
    Zou MF; Cao J; Rodriguez AL; Conn PJ; Newman AH
    Bioorg Med Chem Lett; 2011 May; 21(9):2650-4. PubMed ID: 21295978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 4-aryl piperazine and piperidine amides as novel mGluR5 positive allosteric modulators.
    Xiong H; Brugel TA; Balestra M; Brown DG; Brush KA; Hightower C; Hinkley L; Hoesch V; Kang J; Koether GM; McCauley JP; McLaren FM; Panko LM; Simpson TR; Smith RW; Woods JM; Brockel B; Chhajlani V; Gadient RA; Spear N; Sygowski LA; Zhang M; Arora J; Breysse N; Wilson JM; Isaac M; Slassi A; King MM
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7381-4. PubMed ID: 21067920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Special issue on the pharmacology and medicinal chemistry of allosteric modulators of metabotropic glutamate receptors (mGluRs).
    Lindsley CW
    ACS Chem Neurosci; 2011 Aug; 2(8):379. PubMed ID: 22860165
    [No Abstract]   [Full Text] [Related]  

  • 40. The computational modeling of allosteric modulation of metabotropic glutamate receptors.
    Pérez-Benito L; Llinas Del Torrent C; Pardo L; Tresadern G
    Adv Pharmacol; 2020; 88():1-33. PubMed ID: 32416864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.